
Roche Holding AG
LEI 549300U41AUUVOAAOB37, SWIFT ROCHCHBHXXX
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases. The company is also involved in the provision of pharmaceutical products for various therapeutic areas comprising oncology, virology, inflammation, metabolic disorders, and central nervous system. In addition, it offers a portfolio of diagnostics products, such as blood glucose meters for diabetes patients; point-of-care testing devices for use in doctors offices; high-throughput analyzers for hospitals and commercial diagnostic laboratories; and start-of-the-art instruments and reagents for life science research.
|
General information
-
Organization nameRoche Holding AG
-
Organization statusOperating organization
-
AddressGrenzacherstr. 124 Basel, Switzerland, 4058
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
Stocks
General information
-
Organization nameRoche Holding AG
-
Organization statusOperating organization
-
AddressGrenzacherstr. 124 Basel, Switzerland, 4058
-
Site
-
IR Site
Codes
-
LEI549300U41AUUVOAAOB37
-
SWIFTROCHCHBHXXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000896566
-
UIDCHE101602521









